Mutational profile of myeloproliferative neoplasms detected by a customized NGS-based gene panel
10.3760/cma.j.issn.1009-8158.2019.06.007
- VernacularTitle:基于二代测序的定制化基因panel检测骨髓增殖性肿瘤突变谱
- Author:
Xiu HUANG
1
;
Xuan DENG
;
Xiao XU
;
Xinju ZHANG
;
Yuesheng ZHANG
;
Weizhe MA
;
Tingting HU
;
Gusheng TANG
;
Ming GUAN
Author Information
1. 复旦大学附属华山医院检验科
- Keywords:
Myeloproliferative disorders;
Mutation;
High-throughput nucleotide sequencing
- From:
Chinese Journal of Laboratory Medicine
2019;42(6):427-434
- CountryChina
- Language:Chinese
-
Abstract:
Objective By a sequencing panel consisting of 50 targeted genes, aiming at depicting the molecular landscape of ET, PV, and PMF, which are three major subtypes of MPN, to provide valuable information in the diagnosis and prognosis of MPN.Methods A retrospective study was conducted of 53 patients from Huashan hospital and Changhai hospital. All patients were diagnosed in accordance with the 2016 WHO diagnostic criteria for MPN, including 31 cases of ET(11 males, 20 females, median age 55 years), 17 cases of PV(12 males, 5 females, median age 65 years), and 5 cases of PMF(4 males, 1 females, median age 67 years), and underwent next-generation of DNA sequencing of their bone marrow or blood samples. The genetic analyses were performed on bone marrow or peripheral blood. Referring to COSMIC, dbSNP, Clinvar and other public databases, we analyzed the sequencing data, and elucidated the mutation profile of MPN patients, combining with their clinic information. Results In addition to the typical JAK2, CALR, and MPL mutations, pathogenic mutations in other 11 genes were detected, as well as 4 SNPs that confer individual susceptibility to MPNs (rs4858647, rs9376092, rs58270997, rs621940). The average rate of mutated genes was 2.3 genes per patient. In all patients (53 cases), the mutated genes detected were TET2, EZH2, ASXL1, MIR662, SF3B1, BARD1, DNMT3A, KIT, RUNX1, TP53, NRAS according to their mutational frequency. Conclusions Applying next-generation sequencing technology, multi-gene sequencing of a bunch of typical BCR-ABL-negative MPN patients can be performed at one time within 2 working days, and pathogenic mutations other than JAK2, CALR, MPL can be found, which has a bright prospection in clinic.
